Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

4,160.00p
   
  • Change Today:
      10.00p
  • 52 Week High: 4,500.00
  • 52 Week Low: 2,635.00
  • Currency: UK Pounds
  • Shares Issued: 5.21m
  • Volume: 1,347
  • Market Cap: £216.65m

Bioventix Overview

Bioventix is in the pharma and biotech sector and is currently trading at 4,160.00p per share. In the last year Bioventix's share price has ranged from 2,635.00p to 4,500.00p.

Key Personnel

CEO: Peter John Harrison
CFO: Bruce Hiscock
Chairman: Ian James Nicholson
Finance Director: Treena Joan Turner
Non-Executive Dir: Nicholas (Nick) John McCooke

Contact Details

Address: 27-28 Eastcastle Street, London, W1W 8DH
Website: http://www.bioventix.com

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE AIM All-ShareFTSE AIM 100
ISIN: GB00B4QVDF07

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Bioventix Market Data

Currency UK Pounds
Share Price 4,160.00p
Change Today 10.00p
% Change 0.24 %
52 Week High 4,500.00
52 Week Low 2,635.00
Volume 1,347
Shares Issued 5.21m
Market Cap £216.65m

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
98.25% below the market average98.25% below the market average98.25% below the market average98.25% below the market average98.25% below the market average
89.09% below the sector average89.09% below the sector average89.09% below the sector average89.09% below the sector average89.09% below the sector average
Price Trend
82.13% above the market average82.13% above the market average82.13% above the market average82.13% above the market average82.13% above the market average
54.39% above the sector average54.39% above the sector average54.39% above the sector average54.39% above the sector average54.39% above the sector average
Income
76.09% below the market average76.09% below the market average76.09% below the market average76.09% below the market average76.09% below the market average
20% below the sector average20% below the sector average20% below the sector average20% below the sector average20% below the sector average
Growth
34.93% above the market average34.93% above the market average34.93% above the market average34.93% above the market average34.93% above the market average
8.57% above the sector average8.57% above the sector average8.57% above the sector average8.57% above the sector average8.57% above the sector average

Bioventix Dividends

  Latest Previous
  Interim Final
Ex-Div 09-Apr-20 31-Oct-19
Paid 28-Apr-20 15-Nov-19
Amount 36.00p 43.00p

Trades for 10-Jul-2020

Time Volume / Share Price
17:12 237 @ 4,108.97p
16:01 100 @ 4,130.00p
15:50 237 @ 4,125.00p
15:47 60 @ 4,130.00p
15:42 1 @ 4,100.00p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
Finance Director Treena Joan Turner
CFO Bruce Hiscock

Top of Page